Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

http://www.wikidata.org/entity/Q57114735

about

A review of the medical treatment of primary sclerosing cholangitis in the 21st century Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management Cirrhosis and autoimmune liver disease: Current understanding Facing Terminal Ileitis: Going Beyond Crohn's Disease The Changing Phenotype of Inflammatory Bowel Disease Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Pathogenesis and clinical spectrum of primary sclerosing cholangitis.Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.CCR9 Antagonists in the Treatment of Ulcerative Colitis.Interaction of gut microbiota with bile acid metabolism and its influence on disease states.Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.Recent insights in primary sclerosing cholangitis.Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.Inflammatory Bowel Disease with Primary Sclerosing Cholangitis: a Danish Population-based Cohort Study 1977-2011.Primary sclerosing cholangitis: a clinical update.Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.Recommendations on the use of MRI in PSC-A position statement from the International PSC study group.Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.Factors that Influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis.Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.Risk factors for primary sclerosing cholangitis.Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.Diagnosis, prognosis, and management of primary sclerosing cholangitis.Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.The 2016 diagnostic criteria for primary sclerosing cholangitis.

P2860

Q26771816-645DCEA5-9329-4E6D-8EA2-F0A7EE6882D3 Q26994675-E2B110D9-7C3B-4829-A10A-C849432A032B Q27015831-1AF477E4-BAA8-4FDA-8328-31FDF8A2429B Q28070154-C9191E90-A392-41A9-B490-0AFD3B8326CD Q28077774-1A618E6A-5D54-4AB8-8D2D-5EFC5E580E76 Q28354092-843F6BBA-3B4C-464A-A0C2-6C892F41E4C2 Q30234950-FB186C85-2E08-487F-85E0-B2E1A43C2013 Q33572623-F9473DC0-27B9-48BD-833C-358680745E02 Q33818055-04707B3E-55D6-4324-A873-BE63F6995D1C Q34062402-8D440F72-BA60-4553-BC34-22EDA5361A53 Q35535485-B43C7B1E-7A47-4802-B9B0-2B991F95C0D0 Q35750365-B5E63C36-263A-4FCD-B291-FC58F78F0D01 Q36118943-467080C7-00DF-48F0-A931-04E3A666E440 Q36204422-913CF37A-FD76-400E-85DE-BC649C89180E Q36715515-B23B7357-E4D8-439B-B589-35D92F080989 Q37082378-4E55B4AE-C529-4022-BA2E-072C41E8B4E9 Q37265309-10337FEC-9745-4AA1-B18C-B0998ECC93CB Q37353271-86D2C068-00E5-4949-B312-88260F74D627 Q38019989-FEAD8C42-37D2-441B-B6D4-FFD2DBB0FE56 Q38356761-9549AE10-83FF-4769-ABAB-48FFD6CBD2B3 Q38399155-60F050FD-19FA-4D75-A7E6-18C43DC5BA4C Q38485235-C451B7BC-3775-4806-AF7A-92C10AC47C34 Q38608954-6F3FA5CD-21E3-49C1-B9B0-9D01DB580C2D Q38677506-803E7762-FC2A-4075-8885-59FC96445C1E Q38747656-546FD465-9B72-4FE5-B0BC-F1BC90633B02 Q38919832-70CE4D26-3BF5-4BE3-A802-7B5EAEAE15CC Q39025709-45B79447-D118-46F2-83BB-CF92EE58366D Q39149647-84F7B4AD-98CC-43C4-82AB-9959603D4616 Q39534358-B17D0794-C8FC-4D06-8EB7-5DAA80948F77 Q40130719-723EB877-E711-4156-AC7E-A3DF2A604C08 Q40418336-EC61A921-9BB7-46DE-8E28-113936D03B1E Q40832801-80846DCD-0289-48BE-94CE-EC58B9F07194 Q40989271-B2FB03B3-9A9E-49D9-8E2B-7F18E855DCBF Q41087814-569AA98A-CEAA-4F66-B63C-BE178DE97F11 Q41981735-24D21E8E-00CE-4E78-B05C-F92664B14AF4 Q42253760-C0D377CA-BC56-48FF-890A-4E209E1A1F1A Q44505644-D46B2221-A876-4D54-91AC-277B7B77C5F2 Q46214642-AF81AB81-8EC7-4529-B1BC-6AD1BAE1E4BF Q48151874-DA2D9717-8FA8-4C3A-AC4D-1B1D9E5547DB Q48179061-56917885-CAE4-4599-B1C8-3563ACB08CF3

P2860

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

http://www.wikidata.org/entity/Q57114735

description

im Dezember 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2012

@uk

name

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@en

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@nl

type

label

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@en

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@nl

prefLabel

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@en

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@nl

P1433

Q57114735-0536FEFB-1364-499B-8E0C-F8F5147C5D03

P1476

Q57114735-75343D5A-D7A1-41BE-AF73-71052EA9BEEA

P2093

Q57114735-1C64082A-2B7F-4507-A46E-44B0AB92401C

Q57114735-2538AA85-C92D-4F54-B680-63144C63AEAF

Q57114735-45D1FE0E-2183-4136-9593-E18F923D516D

Q57114735-761751C3-5901-466B-B84E-01EA8C40EB0B

Q57114735-7AC13395-580D-41E2-9BB4-BFAB615B9B1C

Q57114735-8F042F49-2299-4A26-A3FF-DF045C0926F9

Q57114735-A3A434AE-E62B-43EC-949A-98EA8A2E6589

Q57114735-AEDEF011-F6D9-4ACA-9CA8-C3E601B83964

Q57114735-F2493C8B-720C-485A-8248-5F37BDA9A947

P2860

Q57114735-1E68F692-083C-44F6-BA7D-17A0BE58B04A

Q57114735-397BAE35-3B1B-4B66-B5F9-03BDF5CC7AAD

Q57114735-3DC68697-EBC1-4982-AADF-23684A8B352C

Q57114735-3E36B0F5-0A40-4F29-8B22-0A7D21C4AB37

Q57114735-3FB78DBF-76E2-495B-8C65-B440A0CA986A

Q57114735-4CF187D9-3652-4713-965B-B18B931957AC

Q57114735-67BB9819-0AEC-4D50-89E1-40923AE8C42F

Q57114735-7D1C6BFC-B8F5-4A37-93F1-6DD826F5C35B

Q57114735-9BC04FA5-DF54-456A-BBBB-A0B464AAD637

Q57114735-9CE56437-DC27-4B54-BC42-20AFB4094BBF

P304

Q57114735-04DBF3DE-BB6A-4E0A-8FCC-56D1EDE51CD5

P31

Q57114735-A73F5086-8D30-4FF8-8F67-CC758ED47F10

P356

Q57114735-05A2CDCA-B643-4C53-90A1-954119B493B9

P407

Q57114735-5698C6C9-E434-4AFB-8A52-746370F2BE9E

P433

Q57114735-AAACD98A-A678-418A-9038-0FB1C777AD98

P478

Q57114735-65CB8A2A-C981-425E-ACDE-BC758711F824

P577

Q57114735-274C4DC2-4CFD-4A97-98C3-3AF901957F80

P698

Q57114735-EBDF34C0-8E9F-41AF-B58B-0EF86F3735EE

P921

Q57114735-F886516A-C91F-4BB0-83F0-DAB6DC44B0BC

P356

P1433

Inflammatory Bowel Diseases

P1476

Primary sclerosing cholangitis ...... of inflammatory bowel disease

@en

P2093

Alexander C Poen

http://www.w3.org/2001/XMLSchema#string

Ben J M Witteman

http://www.w3.org/2001/XMLSchema#string

Cyriel Y Ponsioen

http://www.w3.org/2001/XMLSchema#string

Hans A R E Tuynman

http://www.w3.org/2001/XMLSchema#string

Joost P H Drenth

http://www.w3.org/2001/XMLSchema#string

Karel J van Erpecum

http://www.w3.org/2001/XMLSchema#string

Karin M J van Nieuwkerk

http://www.w3.org/2001/XMLSchema#string

Kirsten Boonstra

http://www.w3.org/2001/XMLSchema#string

Ulrich Beuers

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.

P304

2270-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.22938

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22407885

http://www.w3.org/2001/XMLSchema#string

P921